by admin | May 7, 2021 | All Articles, Business Start-Up, Employers
At ACLF we help many businesses with preparation for investment rounds or to scale-up. This includes: due diligence; advice; bespoke documents and legal audits. However, it is equally as important to ensure our clients understand all the opportunities available to...
by admin | Mar 1, 2021 | All Articles, Business Start-Up, Commercial Law, Covid-19, Employees, Employers, Employment Law articles
Companies in the UK are looking to implement “no jab, no job” employment contracts for current and future employees. Will this be the future? This is a subject that before the COVID-19 pandemic would barely have been a passing consideration. Whilst this will soon be a...
by admin | Jan 14, 2021 | All Articles, Business Start-Up, Commercial Law
Against the odds, the UK left the EU with a deal (the UK-EU Trade and Cooperation Agreement). However, this deal makes surprisingly few references to financial services and many argue that this means that, for financial transactions, there has still been a hard...
by admin | Nov 24, 2020 | All Articles, Business Start-Up, Commercial Law, Dispute articles, Employees, Employers, Employment Law articles
Introduction We have all witnessed, in some form, the tumultuous way in which 2020 has changed the world. The legal world, which is a sector historically reluctant to change, has seen unprecedented changes to the way in which it operates, and we hope it continues to...
by admin | Nov 24, 2020 | All Articles, Business Start-Up, Commercial Law, Commercial Property, Dispute articles
As the UK prepares for Brexit with the transition period due to end on 31 December 2020, it is an important time for businesses operating in the tech sector. Trade agreement or not there will be significant changes. From 1 January 2021, it is vital that businesses...
by admin | Nov 13, 2020 | All Articles, Associates, Business Start-Up, Commercial Law, Covid-19
The conversation this week has centred on the development of a new vaccine by Pfizer and BioNTech, with preliminary findings showing it can prevent more than 90% of people from getting COVID-19. Pfizer claims it will be able to supply 50 million doses by the end of...
